Related references
Note: Only part of the references are listed.FGF23: Is It Another Biomarker for Phosphate-Calcium Metabolism?
Mariano Rodriguez
ADVANCES IN THERAPY (2020)
The EPO-FGF23 Signaling Pathway in Erythroid Progenitor Cells: Opening a New Area of Research
Annelies J. van Vuren et al.
FRONTIERS IN PHYSIOLOGY (2019)
The Youden Index in the Generalized Receiver Operating Characteristic Curve Context
Pablo Martinez-Camblor et al.
INTERNATIONAL JOURNAL OF BIOSTATISTICS (2019)
FGF23 and Phosphate-Cardiovascular Toxins in CKD
Isabel Vogt et al.
TOXINS (2019)
Advanced chronic kidney disease: Relationship to outcomes post-TAVR, a meta-analysis
Nader Makki et al.
CLINICAL CARDIOLOGY (2018)
C-terminal and intact FGF23 in critical illness and their associations with acute kidney injury and in-hospital mortality
Karolina Rygasiewicz et al.
CYTOKINE (2018)
Plaque Calcification During Atherosclerosis Progression and Regression
Atsushi Shioi et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2018)
FGF23 in Cardiovascular Disease: Innocent Bystander or Active Mediator?
Robert Stoehr et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Circulating Levels of Soluble Klotho and Fibroblast Growth Factor 23 in Diabetic Patients and Its Association with Early Nephropathy
Alfonso Farias-Basulto et al.
ARCHIVES OF MEDICAL RESEARCH (2018)
2017 ESC/EACTS Guidelines for the management of valvular heart disease The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)
Helmut Baumgartner et al.
EUROPEAN HEART JOURNAL (2017)
Calcium Phosphate Product Is Associated with Subclinical Carotid Atherosclerosis in Type 2 Diabetes
Anna Ramirez-Morros et al.
JOURNAL OF DIABETES RESEARCH (2017)
Fibroblast Growth Factor 23 and Cause-Specific Mortality in the General Population: The Northern Manhattan Study
Nao Souma et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
FGF-23 and cardiovascular disease: review of literature
Jasveen Batra et al.
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2016)
Calcific aortic stenosis
Brian R. Lindman et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Youden's Index and the Weight of Evidence
G. Hughes
METHODS OF INFORMATION IN MEDICINE (2015)
Fibroblast growth factor 23 (FGF23) and mortality: The Ludwigshafen Risk and Cardiovascular Health Study
Vincent M. Brandenburg et al.
ATHEROSCLEROSIS (2014)
Serum phosphate is associated with aortic valve calcification in the Multi-ethnic Study of Atherosclerosis (MESA)
Jason P. Linefsky et al.
ATHEROSCLEROSIS (2014)
Associations of FGF-23 and sKlotho with Cardiovascular Outcomes among Patients with CKD Stages 2-4
Sarah Seiler et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2014)
Coupling fibroblast growth factor 23 production and cleavage: iron deficiency, rickets, and kidney disease
Myles Wolf et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Fibroblast Growth Factor-23, Cardiovascular Prognosis, and Benefit of Angiotensin-Converting Enzyme Inhibition in Stable Ischemic Heart Disease
Jacob A. Udell et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Accuracy of the MDRD (Modification of Diet in Renal Disease) Study and CKD-EPI (CKD Epidemiology Collaboration) Equations for Estimation of GFR in the Elderly
Hannah S. Kilbride et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2013)
Prognostic Value of Chronic Kidney Disease After Transcatheter Aortic Valve Implantation
Masanori Yamamoto et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Guidelines on the management of valvular heart disease (version 2012)
Alec Vahanian et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document (VARC-2)
Arie Pieter Kappetein et al.
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY (2012)
Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease
L. Darryl Quarles
EXPERIMENTAL CELL RESEARCH (2012)
Dietary Phosphate Modulates Atherogenesis and Insulin Resistance in Apolipoprotein E Knockout Mice-Brief Report
Timothy Ellam et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Fibroblast Growth Factor 23 and Risks of Mortality and End-Stage Renal Disease in Patients With Chronic Kidney Disease
Tamara Isakova et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Fibroblast growth factors: from molecular evolution to roles in development, metabolism and disease
Nobuyuki Itoh et al.
JOURNAL OF BIOCHEMISTRY (2011)
The Associations of Fibroblast Growth Factor 23 and Uncarboxylated Matrix Gla Protein With Mortality in Coronary Artery Disease: The Heart and Soul Study
Benjamin D. Parker et al.
ANNALS OF INTERNAL MEDICINE (2010)
Isolated C-terminal tail of FGF23 alleviates hypophosphatemia by inhibiting FGF23-FGFR-Klotho complex formation
Regina Goetz et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population
Majd A. I. Mirza et al.
ATHEROSCLEROSIS (2009)
The FgF23-Klotho axis: endocrine regulation of phosphate homeostasis
M. Shawkat Razzaque
NATURE REVIEWS ENDOCRINOLOGY (2009)
Vascular calcifications, vertebral fractures and mortality in haemodialysis patients
Minerva Rodriguez-Garcia et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
High levels of serum fibroblast growth factor (FGF)-23 are associated with increased mortality in long haemodialysis patients
Guillaume Jean et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
Orlando M. Gutierrez et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: The mild to moderate kidney disease (MMKD) study
Danilo Fliser et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism
T Shimada et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Transgenic mice expressing fibroblast growth factor 23 under the control of the α1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis
T Larsson et al.
ENDOCRINOLOGY (2004)
Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia
T Shimada et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Share Paper
